Synthesis and Antiviral Bioactivity of Novel 3-((2-((1<i>E</i>,4<i>E</i>)-3-Oxo-5-arylpenta-1,4-dien-1-yl)phenoxy)methyl)-4(3<i>H</i>)-quinazolinone Derivatives
作者:Juan Ma、Pei Li、Xiangyang Li、Qingcai Shi、Zhihua Wan、Deyu Hu、Linhong Jin、Baoan Song
DOI:10.1021/jf502162y
日期:2014.9.10
A series of novel 3-((2-((1E,4E)-3-oxo-5-arylpenta-1,4-dien-1-yl)phenoxy)methyl)-4(3H)-quinazolinone derivatives were designed and synthesized. Antiviral bioassays indicated that a few of the compounds exhibited higher antiviral activities against tobacco mosaic virus (TMV) in vivo than the commercial agent ningnanmycin. In particular, compounds A5, A12, A25, and A27 possessed appreciable curative
一系列新颖的3-((2-((1 E,4 E)-3-氧代-5-芳基戊-1,4-二烯-1-基)苯氧基)甲基)-4(3 H)-喹唑啉酮衍生物被设计和合成。抗病毒生物测定法表明,与市售药物宁南霉素相比,一些化合物在体内对烟草花叶病毒(TMV)表现出更高的抗病毒活性。特别地,化合物A 5,A 12,A 25和A 27在体内对TMV具有可观的治愈性生物活性,50%有效浓度范围为132.25至156.10μg/ mL。这些值优于宁南霉素(281.22μg/ mL)的值,表明新颖的4(3 H含有1,4-戊二烯-3-一个部分的)-喹唑啉酮衍生物可以有效地控制TMV。在野外研究中评估抗病毒特性以及这些衍生物增强的抗病毒活性的潜在机制是未来研究的有趣话题。